STOCK TITAN

Macrogenics Inc - MGNX STOCK NEWS

Welcome to our dedicated news page for Macrogenics (Ticker: MGNX), a resource for investors and traders seeking the latest updates and insights on Macrogenics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Macrogenics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Macrogenics's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.84%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.91%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
clinical trial
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.05%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
none
Macrogenics Inc

Nasdaq:MGNX

MGNX Rankings

MGNX Stock Data

919.00M
52.11M
2.66%
99.99%
8.97%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Rockville

About MGNX

a career at macrogenics could be waiting for you! please click on "careers" ---------------------------->>> to learn more. macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. macrogenics creates both differentiated molecules that are directed to novel cancer targets, as well as “bio-betters,” which are drugs designed to improve upon marketed medicines. the combination of macrogenics’ technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. these are exciting times at macrogenics and we hope that you will take the opportunity to learn more about our organization, our pipeline and to view our job opportunities!